市場調査レポート
商品コード
1172616

CDMO(医薬品開発製造受託)アウトソーシングの世界市場 2023-2027

Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market 2023-2027

出版日: | 発行: TechNavio | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
CDMO(医薬品開発製造受託)アウトソーシングの世界市場 2023-2027
出版日: 2022年11月30日
発行: TechNavio
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、CDMO(医薬品開発製造受託)アウトソーシングの市場規模は、2023年から2027年の間に841億4,000万米ドルの増加が見込まれ、予測期間中に12.76%のCAGRで成長すると予測しています。当レポートでは、CDMO(医薬品開発製造受託)アウトソーシング市場の全体分析、市場規模と予測、動向、成長促進要因・課題、さらに約25社のベンダーを網羅したベンダー分析などをお届けします。

現在の世界の市場動向と促進要因、市場環境全体に関する最新分析を提供しています。

市場は、製薬業界の成長、ワンストップサービス型CDMOの需要の増加、CDMOによる運用コストと資本コストの削減のサポートによって牽引されています。

CDMO(医薬品開発製造受託)アウトソーシング市場の分析には、製品、サービス、地域が含まれます。

本調査では、今後数年間のCDMO(医薬品開発製造受託)アウトソーシング市場の成長を促進する主要な理由の1つとして、CDMOによる分析の利用が拡大していることを挙げています。また、細胞治療や遺伝子治療におけるCDMOの需要の高まりや、市場統合の進展も、市場の大きな需要につながると考えられます。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2022
  • 市場の見通し:2022-2027年の予測

第4章 市場規模実績

  • 世界のCDMO(医薬品開発製造受託)アウトソーシング市場2017~2021年
  • 製品セグメント分析2017-2021
  • サービスセグメント分析2017-2021
  • 地域セグメント分析2017-2021
  • 国セグメント分析2017-2021

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 製品別の市場セグメンテーション

  • 市場内訳
  • 製品別比較
  • 低分子 - 市場規模と予測 2022-2027
  • 生物製剤 - 市場規模と予測 2022-2027
  • 製品別の市場機会

第7章 サービス別市場セグメンテーション

  • 市場内訳
  • サービス別比較
  • API/原薬 - 市場規模と予測 2022-2027
  • 医薬品製造 - 市場規模と予測 2022-2027
  • 包装 - 市場規模と予測 2022-2027
  • サービス別の市場機会

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米 - 市場規模と予測 2022-2027
  • 欧州 - 市場規模と予測 2022-2027
  • APAC - 市場規模と予測 2022-2027
  • 南米 - 市場規模と予測 2022-2027
  • 中東およびアフリカ - 市場規模と予測 2022-2027
  • 米国 - 市場規模と予測 2022-2027
  • 中国 - 市場規模と予測 2022-2027
  • 英国 - 市場規模と予測 2022-2027
  • ドイツ - 市場規模と予測 2022-2027
  • インド - 市場規模と予測 2022-2027
  • 地域情勢別の市場機会

第10章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第11章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第12章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Aenova Holding GmbH
  • Alcami Corp.
  • Almac Group Ltd.
  • Boehringer Ingelheim International GmbH
  • Catalent Inc.
  • Celonic AG
  • Corden Pharma International GmbH
  • Curia Inc.
  • Eurofins Scientific SE
  • FAMAR Health Care Services
  • FUJIFILM Holdings Corp
  • Lonza Group Ltd.
  • Piramal Enterprises Ltd.
  • Recipharm AB
  • Siegfried Holding AG

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Product
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Service
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits10: Parent market
  • Exhibits11: Market Characteristics
  • Exhibits12: Offerings of vendors included in the market definition
  • Exhibits13: Market segments
  • Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibits18: Historic Market Size - Data Table on Global contract development and manufacturing organization (CDMO) outsourcing market 2017 - 2021 ($ billion)
  • Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
  • Exhibits20: Historic Market Size - Services Segment 2017 - 2021 ($ billion)
  • Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
  • Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
  • Exhibits23: Five forces analysis - Comparison between 2022 and 2027
  • Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • Exhibits29: Chart on Market condition - Five forces 2022 and 2027
  • Exhibits30: Chart on Product - Market share 2022-2027 (%)
  • Exhibits31: Data Table on Product - Market share 2022-2027 (%)
  • Exhibits32: Chart on Comparison by Product
  • Exhibits33: Data Table on Comparison by Product
  • Exhibits34: Chart on Small molecules - Market size and forecast 2022-2027 ($ billion)
  • Exhibits35: Data Table on Small molecules - Market size and forecast 2022-2027 ($ billion)
  • Exhibits36: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
  • Exhibits37: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
  • Exhibits38: Chart on Biologics - Market size and forecast 2022-2027 ($ billion)
  • Exhibits39: Data Table on Biologics - Market size and forecast 2022-2027 ($ billion)
  • Exhibits40: Chart on Biologics - Year-over-year growth 2022-2027 (%)
  • Exhibits41: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
  • Exhibits42: Market opportunity by Product ($ billion)
  • Exhibits43: Chart on Service - Market share 2022-2027 (%)
  • Exhibits44: Data Table on Service - Market share 2022-2027 (%)
  • Exhibits45: Chart on Comparison by Service
  • Exhibits46: Data Table on Comparison by Service
  • Exhibits47: Chart on API/bulk drugs - Market size and forecast 2022-2027 ($ billion)
  • Exhibits48: Data Table on API/bulk drugs - Market size and forecast 2022-2027 ($ billion)
  • Exhibits49: Chart on API/bulk drugs - Year-over-year growth 2022-2027 (%)
  • Exhibits50: Data Table on API/bulk drugs - Year-over-year growth 2022-2027 (%)
  • Exhibits51: Chart on Drug product manufacturing - Market size and forecast 2022-2027 ($ billion)
  • Exhibits52: Data Table on Drug product manufacturing - Market size and forecast 2022-2027 ($ billion)
  • Exhibits53: Chart on Drug product manufacturing - Year-over-year growth 2022-2027 (%)
  • Exhibits54: Data Table on Drug product manufacturing - Year-over-year growth 2022-2027 (%)
  • Exhibits55: Chart on Packaging - Market size and forecast 2022-2027 ($ billion)
  • Exhibits56: Data Table on Packaging - Market size and forecast 2022-2027 ($ billion)
  • Exhibits57: Chart on Packaging - Year-over-year growth 2022-2027 (%)
  • Exhibits58: Data Table on Packaging - Year-over-year growth 2022-2027 (%)
  • Exhibits59: Market opportunity by Service ($ billion)
  • Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibits63: Chart on Geographic comparison
  • Exhibits64: Data Table on Geographic comparison
  • Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibits73: Chart on APAC - Market size and forecast 2022-2027 ($ billion)
  • Exhibits74: Data Table on APAC - Market size and forecast 2022-2027 ($ billion)
  • Exhibits75: Chart on APAC - Year-over-year growth 2022-2027 (%)
  • Exhibits76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
  • Exhibits77: Chart on South America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits78: Data Table on South America - Market size and forecast 2022-2027 ($ billion)
  • Exhibits79: Chart on South America - Year-over-year growth 2022-2027 (%)
  • Exhibits80: Data Table on South America - Year-over-year growth 2022-2027 (%)
  • Exhibits81: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ billion)
  • Exhibits82: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ billion)
  • Exhibits83: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
  • Exhibits84: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
  • Exhibits85: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibits86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibits87: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibits88: Data Table on US - Year-over-year growth 2022-2027 (%)
  • Exhibits89: Chart on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibits90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibits91: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibits92: Data Table on China - Year-over-year growth 2022-2027 (%)
  • Exhibits93: Chart on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibits94: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibits95: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits96: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • Exhibits97: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibits98: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibits99: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibits101: Chart on India - Market size and forecast 2022-2027 ($ billion)
  • Exhibits102: Data Table on India - Market size and forecast 2022-2027 ($ billion)
  • Exhibits103: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibits104: Data Table on India - Year-over-year growth 2022-2027 (%)
  • Exhibits105: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits106: Impact of drivers and challenges in 2022 and 2027
  • Exhibits107: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits108: Overview on factors of disruption
  • Exhibits109: Impact of key risks on business
  • Exhibits110: Vendors covered
  • Exhibits111: Matrix on vendor position and classification
  • Exhibits112: Aenova Holding GmbH - Overview
  • Exhibits113: Aenova Holding GmbH - Product / Service
  • Exhibits114: Aenova Holding GmbH - Key offerings
  • Exhibits115: Alcami Corp. - Overview
  • Exhibits116: Alcami Corp. - Product / Service
  • Exhibits117: Alcami Corp. - Key offerings
  • Exhibits118: Almac Group Ltd. - Overview
  • Exhibits119: Almac Group Ltd. - Product / Service
  • Exhibits120: Almac Group Ltd. - Key offerings
  • Exhibits121: Boehringer Ingelheim International GmbH - Overview
  • Exhibits122: Boehringer Ingelheim International GmbH - Business segments
  • Exhibits123: Boehringer Ingelheim International GmbH - Key news
  • Exhibits124: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibits125: Boehringer Ingelheim International GmbH - Segment focus
  • Exhibits126: Catalent Inc. - Overview
  • Exhibits127: Catalent Inc. - Business segments
  • Exhibits128: Catalent Inc. - Key news
  • Exhibits129: Catalent Inc. - Key offerings
  • Exhibits130: Catalent Inc. - Segment focus
  • Exhibits131: Celonic AG - Overview
  • Exhibits132: Celonic AG - Product / Service
  • Exhibits133: Celonic AG - Key offerings
  • Exhibits134: Corden Pharma International GmbH - Overview
  • Exhibits135: Corden Pharma International GmbH - Product / Service
  • Exhibits136: Corden Pharma International GmbH - Key offerings
  • Exhibits137: Curia Inc. - Overview
  • Exhibits138: Curia Inc. - Product / Service
  • Exhibits139: Curia Inc. - Key news
  • Exhibits140: Curia Inc. - Key offerings
  • Exhibits141: Eurofins Scientific SE - Overview
  • Exhibits142: Eurofins Scientific SE - Business segments
  • Exhibits143: Eurofins Scientific SE - Key news
  • Exhibits144: Eurofins Scientific SE - Key offerings
  • Exhibits145: Eurofins Scientific SE - Segment focus
  • Exhibits146: FAMAR Health Care Services - Overview
  • Exhibits147: FAMAR Health Care Services - Product / Service
  • Exhibits148: FAMAR Health Care Services - Key offerings
  • Exhibits149: FUJIFILM Holdings Corp - Overview
  • Exhibits150: FUJIFILM Holdings Corp - Business segments
  • Exhibits151: FUJIFILM Holdings Corp - Key offerings
  • Exhibits152: FUJIFILM Holdings Corp - Segment focus
  • Exhibits153: Lonza Group Ltd. - Overview
  • Exhibits154: Lonza Group Ltd. - Business segments
  • Exhibits155: Lonza Group Ltd. - Key news
  • Exhibits156: Lonza Group Ltd. - Key offerings
  • Exhibits157: Lonza Group Ltd. - Segment focus
  • Exhibits158: Piramal Enterprises Ltd. - Overview
  • Exhibits159: Piramal Enterprises Ltd. - Business segments
  • Exhibits160: Piramal Enterprises Ltd. - Key offerings
  • Exhibits161: Piramal Enterprises Ltd. - Segment focus
  • Exhibits162: Recipharm AB - Overview
  • Exhibits163: Recipharm AB - Business segments
  • Exhibits164: Recipharm AB - Key offerings
  • Exhibits165: Recipharm AB - Segment focus
  • Exhibits166: Siegfried Holding AG - Overview
  • Exhibits167: Siegfried Holding AG - Business segments
  • Exhibits168: Siegfried Holding AG - Key offerings
  • Exhibits169: Siegfried Holding AG - Segment focus
  • Exhibits170: Inclusions checklist
  • Exhibits171: Exclusions checklist
  • Exhibits172: Currency conversion rates for US$
  • Exhibits173: Research methodology
  • Exhibits174: Validation techniques employed for market sizing
  • Exhibits175: Information sources
  • Exhibits176: List of abbreviations
目次
Product Code: IRTNTR43489

Technavio has been monitoring the contract development and manufacturing organization (CDMO) outsourcing market and it is poised to grow by $84.14 bn during 2023-2027, accelerating at a CAGR of 12.76% during the forecast period. Our report on the contract development and manufacturing organization (CDMO) outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing pharmaceutical industry, increasing demand for one-stop-shop CDMOs, and support of CDMO in reducing operational and capital expenses.

The contract development and manufacturing organization (CDMO) outsourcing market analysis include Product, Service, and Geography

Technavio's contract development and manufacturing organization (CDMO) outsourcing market is segmented as below:

By Product

  • Small molecules
  • Biologics

By Service

  • API/bulk drugs
  • Drug product manufacturing
  • Packaging

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • South America
  • Middle East and Africa

This study identifies the growing use of analytics by CDMOs as one of the prime reasons driving the contract development and manufacturing organization (CDMO) outsourcing market growth during the next few years. Also, growing demand for CDMOs for cell and gene therapies and increasing market consolidation will lead to sizable demand in the market.

  • Contract development and manufacturing organization (CDMO) outsourcing market sizing
  • Contract development and manufacturing organization (CDMO) outsourcing market forecast
  • Contract development and manufacturing organization (CDMO) outsourcing market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contract development and manufacturing organization (CDMO) outsourcing market vendors that include Alcami Corp., Almac Group Ltd., Boehringer Ingelheim International GmbH, Catalent Inc., Celonic AG, Corden Pharma International GmbH, Eurofins Scientific SE, FAMAR Health Care Services, FUJIFILM Holdings Corp, Lonza Group Ltd., Piramal Enterprises Ltd., Recipharm AB, Siegfried Holding AG, The Lubrizol Corp., Thermo Fisher Scientific Inc., Aenova Holding GmbH, Curia Inc., Laboratory Corp. of America Holdings, NextPharma GmbH, and Vetter Pharma-Fertigung GmbH & Co. KG. Also, the contract development and manufacturing organization (CDMO) outsourcing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Service
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global contract development and manufacturing organization (CDMO) outsourcing market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on Global contract development and manufacturing organization (CDMO) outsourcing market 2017 - 2021 ($ billion)
  • 4.2 Product Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
  • 4.3 Services Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Services Segment 2017 - 2021 ($ billion)
  • 4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
  • 4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

  • 5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
  • 5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

  • 6.1 Market segments
  • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
  • 6.2 Comparison by Product
  • Exhibit 32: Chart on Comparison by Product
  • Exhibit 33: Data Table on Comparison by Product
  • 6.3 Small molecules - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Small molecules - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 35: Data Table on Small molecules - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 36: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
  • 6.4 Biologics - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Biologics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 39: Data Table on Biologics - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 40: Chart on Biologics - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Product
  • Exhibit 42: Market opportunity by Product ($ billion)

7 Market Segmentation by Service

  • 7.1 Market segments
  • Exhibit 43: Chart on Service - Market share 2022-2027 (%)
  • Exhibit 44: Data Table on Service - Market share 2022-2027 (%)
  • 7.2 Comparison by Service
  • Exhibit 45: Chart on Comparison by Service
  • Exhibit 46: Data Table on Comparison by Service
  • 7.3 API/bulk drugs - Market size and forecast 2022-2027
  • Exhibit 47: Chart on API/bulk drugs - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 48: Data Table on API/bulk drugs - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 49: Chart on API/bulk drugs - Year-over-year growth 2022-2027 (%)
  • Exhibit 50: Data Table on API/bulk drugs - Year-over-year growth 2022-2027 (%)
  • 7.4 Drug product manufacturing - Market size and forecast 2022-2027
  • Exhibit 51: Chart on Drug product manufacturing - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 52: Data Table on Drug product manufacturing - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 53: Chart on Drug product manufacturing - Year-over-year growth 2022-2027 (%)
  • Exhibit 54: Data Table on Drug product manufacturing - Year-over-year growth 2022-2027 (%)
  • 7.5 Packaging - Market size and forecast 2022-2027
  • Exhibit 55: Chart on Packaging - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 56: Data Table on Packaging - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 57: Chart on Packaging - Year-over-year growth 2022-2027 (%)
  • Exhibit 58: Data Table on Packaging - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Service
  • Exhibit 59: Market opportunity by Service ($ billion)

8 Customer Landscape

  • 8.1 Customer landscape overview
  • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
  • Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
  • 9.2 Geographic comparison
  • Exhibit 63: Chart on Geographic comparison
  • Exhibit 64: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
  • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 APAC - Market size and forecast 2022-2027
  • Exhibit 73: Chart on APAC - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 74: Data Table on APAC - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 75: Chart on APAC - Year-over-year growth 2022-2027 (%)
  • Exhibit 76: Data Table on APAC - Year-over-year growth 2022-2027 (%)
  • 9.6 South America - Market size and forecast 2022-2027
  • Exhibit 77: Chart on South America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 78: Data Table on South America - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 79: Chart on South America - Year-over-year growth 2022-2027 (%)
  • Exhibit 80: Data Table on South America - Year-over-year growth 2022-2027 (%)
  • 9.7 Middle East and Africa - Market size and forecast 2022-2027
  • Exhibit 81: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 82: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 83: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
  • Exhibit 84: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
  • 9.8 US - Market size and forecast 2022-2027
  • Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.9 China - Market size and forecast 2022-2027
  • Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.10 UK - Market size and forecast 2022-2027
  • Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.11 Germany - Market size and forecast 2022-2027
  • Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.12 India - Market size and forecast 2022-2027
  • Exhibit 101: Chart on India - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 102: Data Table on India - Market size and forecast 2022-2027 ($ billion)
  • Exhibit 103: Chart on India - Year-over-year growth 2022-2027 (%)
  • Exhibit 104: Data Table on India - Year-over-year growth 2022-2027 (%)
  • 9.13 Market opportunity By Geographical Landscape
  • Exhibit 105: Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
  • Exhibit 106: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
  • Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
  • Exhibit 108: Overview on factors of disruption
  • 11.4 Industry risks
  • Exhibit 109: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
  • Exhibit 110: Vendors covered
  • 12.2 Market positioning of vendors
  • Exhibit 111: Matrix on vendor position and classification
  • 12.3 Aenova Holding GmbH
  • Exhibit 112: Aenova Holding GmbH - Overview
  • Exhibit 113: Aenova Holding GmbH - Product / Service
  • Exhibit 114: Aenova Holding GmbH - Key offerings
  • 12.4 Alcami Corp.
  • Exhibit 115: Alcami Corp. - Overview
  • Exhibit 116: Alcami Corp. - Product / Service
  • Exhibit 117: Alcami Corp. - Key offerings
  • 12.5 Almac Group Ltd.
  • Exhibit 118: Almac Group Ltd. - Overview
  • Exhibit 119: Almac Group Ltd. - Product / Service
  • Exhibit 120: Almac Group Ltd. - Key offerings
  • 12.6 Boehringer Ingelheim International GmbH
  • Exhibit 121: Boehringer Ingelheim International GmbH - Overview
  • Exhibit 122: Boehringer Ingelheim International GmbH - Business segments
  • Exhibit 123: Boehringer Ingelheim International GmbH - Key news
  • Exhibit 124: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibit 125: Boehringer Ingelheim International GmbH - Segment focus
  • 12.7 Catalent Inc.
  • Exhibit 126: Catalent Inc. - Overview
  • Exhibit 127: Catalent Inc. - Business segments
  • Exhibit 128: Catalent Inc. - Key news
  • Exhibit 129: Catalent Inc. - Key offerings
  • Exhibit 130: Catalent Inc. - Segment focus
  • 12.8 Celonic AG
  • Exhibit 131: Celonic AG - Overview
  • Exhibit 132: Celonic AG - Product / Service
  • Exhibit 133: Celonic AG - Key offerings
  • 12.9 Corden Pharma International GmbH
  • Exhibit 134: Corden Pharma International GmbH - Overview
  • Exhibit 135: Corden Pharma International GmbH - Product / Service
  • Exhibit 136: Corden Pharma International GmbH - Key offerings
  • 12.10 Curia Inc.
  • Exhibit 137: Curia Inc. - Overview
  • Exhibit 138: Curia Inc. - Product / Service
  • Exhibit 139: Curia Inc. - Key news
  • Exhibit 140: Curia Inc. - Key offerings
  • 12.11 Eurofins Scientific SE
  • Exhibit 141: Eurofins Scientific SE - Overview
  • Exhibit 142: Eurofins Scientific SE - Business segments
  • Exhibit 143: Eurofins Scientific SE - Key news
  • Exhibit 144: Eurofins Scientific SE - Key offerings
  • Exhibit 145: Eurofins Scientific SE - Segment focus
  • 12.12 FAMAR Health Care Services
  • Exhibit 146: FAMAR Health Care Services - Overview
  • Exhibit 147: FAMAR Health Care Services - Product / Service
  • Exhibit 148: FAMAR Health Care Services - Key offerings
  • 12.13 FUJIFILM Holdings Corp
  • Exhibit 149: FUJIFILM Holdings Corp - Overview
  • Exhibit 150: FUJIFILM Holdings Corp - Business segments
  • Exhibit 151: FUJIFILM Holdings Corp - Key offerings
  • Exhibit 152: FUJIFILM Holdings Corp - Segment focus
  • 12.14 Lonza Group Ltd.
  • Exhibit 153: Lonza Group Ltd. - Overview
  • Exhibit 154: Lonza Group Ltd. - Business segments
  • Exhibit 155: Lonza Group Ltd. - Key news
  • Exhibit 156: Lonza Group Ltd. - Key offerings
  • Exhibit 157: Lonza Group Ltd. - Segment focus
  • 12.15 Piramal Enterprises Ltd.
  • Exhibit 158: Piramal Enterprises Ltd. - Overview
  • Exhibit 159: Piramal Enterprises Ltd. - Business segments
  • Exhibit 160: Piramal Enterprises Ltd. - Key offerings
  • Exhibit 161: Piramal Enterprises Ltd. - Segment focus
  • 12.16 Recipharm AB
  • Exhibit 162: Recipharm AB - Overview
  • Exhibit 163: Recipharm AB - Business segments
  • Exhibit 164: Recipharm AB - Key offerings
  • Exhibit 165: Recipharm AB - Segment focus
  • 12.17 Siegfried Holding AG
  • Exhibit 166: Siegfried Holding AG - Overview
  • Exhibit 167: Siegfried Holding AG - Business segments
  • Exhibit 168: Siegfried Holding AG - Key offerings
  • Exhibit 169: Siegfried Holding AG - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
  • Exhibit 170: Inclusions checklist
  • Exhibit 171: Exclusions checklist
  • 13.3 Currency conversion rates for US$
  • Exhibit 172: Currency conversion rates for US$
  • 13.4 Research methodology
  • Exhibit 173: Research methodology
  • Exhibit 174: Validation techniques employed for market sizing
  • Exhibit 175: Information sources
  • 13.5 List of abbreviations
  • Exhibit 176: List of abbreviations
    • adoption of multichannel marketing strategies: The key vendors in the market are striving to expand their target customer base by investing in marketing and promotional activities. Large specialized consumer service providers aim at strengthening their presence by investing in brand visibility activities, celebrity endorsements, and marketing through channels such as television, radio, the Internet, print media, posters, and direct mails. The competitors also use a targeted advertising approach and launch advertisements that are designed and crafted to promote the services and communicate the brand positioning.
    • attrition and training: Professional, skilled, and unskilled workforce is required to provide specialized consumer services. However, there is a shortage of skilled and professional workforce to meet the demand. For instance, in security services, a skilled workforce is required when new monitoring devices and security gadgets are developed and adopted. Several vendors provide rigorous training to their employees about the handling of critical tasks while serving specialized consumer services. However, the retention of such a workforce is a major challenge.